MALDEN, Mass., March 8, 2019 /PRNewswire-PRWeb/ -- NanoFUSE Biologics announced today that it will be unveiling
NanoFUSE is working with key opinion leaders like Harvard-trained Orthopaedic Spine Surgeon, Dr. Jeffrey Carlson, on varying the handling characteristics of the NanoFUSE putty form. NanoFUSE President, Jake Lubinski, sees opportunities to develop customized forms of this innovative biologic for key surgeons which will further expand the product offering.
After visiting NanoFUSE's manufacturing site last week, Mr. Lubinski said, "I'm so excited about the engineers and development that's going on with NanoFUSE right now. Our new offerings are going to be of a caliber to blow you away at AAOS."
NanoFUSE and KICVentures CEO, Dr. Kingsley R. Chin, said that the launch of new products is important because, "NanoFUSE is the world's first bioactive glass with DBM. The current NanoFUSE putty is just one of the six possible variations of this one-of-a-kind synthetic, DBM plus bioactive glass, biologic."
The company will be represented at AAOS at Booth # 2273 from 9:00 am- 5:00 pm and will host a special event with Dr. Patrick Joyner speaking on "NanoFUSE Biologics -My Experience & Early Clinical Results" on Thursday, March 14 from 5:30-6:00 pm at the Venetian Resort Hotel Casino.
SOURCE NanoFUSE Biologics
Subscribe to our Free Newsletters!